Home Cart Sign in  
Chemical Structure| 16311-69-6 Chemical Structure| 16311-69-6

Structure of 16311-69-6

Chemical Structure| 16311-69-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 16311-69-6 ]

CAS No. :16311-69-6
Formula : C7H12INOS
M.W : 285.15
SMILES Code : OCCC1=C(C)[N+](C)=CS1.[I-]
MDL No. :MFCD00011958
InChI Key :GDNOYVMHHMSZJV-UHFFFAOYSA-M
Pubchem ID :9838770

Safety of [ 16311-69-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 16311-69-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 5
Fraction Csp3 0.57
Num. rotatable bonds 2
Num. H-bond acceptors 1.0
Num. H-bond donors 1.0
Molar Refractivity 57.83
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

52.35 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

-1.01
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.96
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-2.58
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.92
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.24
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.31

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.05
Solubility 0.256 mg/ml ; 0.000897 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.68
Solubility 0.59 mg/ml ; 0.00207 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.47
Solubility 9.71 mg/ml ; 0.034 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.65 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<0.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.54

Application In Synthesis of [ 16311-69-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 16311-69-6 ]

[ 16311-69-6 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 137-00-8 ]
  • [ 74-88-4 ]
  • [ 16311-69-6 ]
YieldReaction ConditionsOperation in experiment
96.3% for 2h;Reflux; 5-(2-hydroxyethyl)-4-methylthiazole 7 (3.0 g, 21.0 mmol) and methyl iodide (2.64 mL, 42.0 mmol) were mixed and refluxed for 2 h. After evaporation of excess methyl iodide, to the residual brown syrup was added ether (50 mL) and stirred for 30 min, the precipitate was filtered to get 17 as a pale-yellow solid (5.76 g, 96.3%). Mp: 82-84 C; 1H NMR (D2O, ppm): 4.14 (s, 3 H, CH3N), 3.90 (t, 2 H, CH2CH2O, J = 5.6 Hz), 3.19 (t, 2 H, CH2CH2O, J = 6.0 Hz), 2.53 (s, 3 H, CCH3).
96.2% at 50℃; for 2h; 5-(2-Hydroxyethyl)-4-methylthiazole (100.0 g, 698.2 mmol) and methyl iodide (100.0 mL, 1500.0 mmol) were mixed and refluxed for 2 h. After evaporation of excess methyl iodide, to the residual brown syrup was added ether (100 mL) and stirred for 30 min, the precipitate was filtered to yield 9 as a pale-yellow solid (191.4 g, 96.2%). Mp: 82-84 C. 1H-NMR (DMSO-d6, ppm): 2.43 (s, 3H), 3.03 (t, 2H, J = 5.5 Hz), 3.63 (t, 2H, J = 5.6 Hz), 4.09 (s, 3H), 9.96 (s, 1H); MS m/z [M]+ calculated for C7H12NS+: 158.1; found: 158.1.
93% at 70℃; for 4h; Take 2- (4-methyl-5-thiazolyl) ethanol8.6 g (60 mmol) was added dropwise to 17.04 g (120 mmol) of methyl iodide, and the mixture was heated to 70 C and stirred for 4 hours. The solution was monitored by thin layer chromatography. After completion of the reaction, the excess methyl iodide was distilled off to give 15.9 g of a yellow powder as a solid, the yield was 93%, and the reaction was carried out without purification.
191.4 g for 2h;Reflux; 4-Methyl-5-thiazole ethanol (100 g, 698.2 mmol) And iodomethane (100 ml, 1500. Ommol) The mixture was heated to reflux in an oil bath, 2h after the reaction was complete. After removing excess methyl iodide under reduced pressure, The iodide was obtained as a yellow crystalline solid N, 4-dimethyl-5- [2- (hydroxy) ethyl] thiazole (191.4 g)

  • 2
  • [ 542-85-8 ]
  • [ 16311-69-6 ]
  • [ 23972-02-3 ]
  • 3
  • [ 726-42-1 ]
  • [ 16311-69-6 ]
  • [ 52534-28-8 ]
  • 5
  • [ 1215-57-2 ]
  • [ 16311-69-6 ]
  • [ 52579-94-9 ]
  • 6
  • [ 1215-57-2 ]
  • [ 16311-69-6 ]
  • [ 52534-37-9 ]
  • 7
  • [ 738-66-9 ]
  • [ 16311-69-6 ]
  • [ 52579-93-8 ]
  • 8
  • [ 738-66-9 ]
  • [ 16311-69-6 ]
  • [ 52534-36-8 ]
  • 9
  • [ 16311-69-6 ]
  • 2-(3,4-dimethyl-thiazolidin-5-yl)-ethanol [ No CAS ]
  • 10
  • [ 16311-69-6 ]
  • 5-(2-hydroxy-ethyl)-3,4-dimethyl-thiazolium betaine [ No CAS ]
  • 11
  • [ 16311-69-6 ]
  • [ 622-59-3 ]
  • [ 21164-15-8 ]
  • 12
  • [ 16311-69-6 ]
  • [ 622-59-3 ]
  • [ 52534-44-8 ]
  • 13
  • [ 16311-69-6 ]
  • [ 100-52-7 ]
  • [ 28168-51-6 ]
  • 14
  • [ 16311-69-6 ]
  • [ 103-72-0 ]
  • 3,4-dimethyl-2-(phenyl-thiocarbamoyl)-5-[2-(phenyl-thiocarbamoyloxy)-ethyl]-thiazolium betaine [ No CAS ]
  • 15
  • [ 16311-69-6 ]
  • [ 103-72-0 ]
  • [ 20939-90-6 ]
  • 16
  • [ 16311-69-6 ]
  • [ 2131-55-7 ]
  • [ 20940-00-5 ]
  • 17
  • [ 16311-69-6 ]
  • [ 2131-55-7 ]
  • [ 20939-94-0 ]
  • 18
  • [ 16311-69-6 ]
  • [ 75-07-0 ]
  • [ 52084-19-2 ]
  • 19
  • [ 16311-69-6 ]
  • [ 34132-22-4 ]
  • [ 52534-30-2 ]
  • 20
  • [ 16311-69-6 ]
  • [ 556-61-6 ]
  • [ 23972-00-1 ]
  • 21
  • [ 16311-69-6 ]
  • [ 622-16-2 ]
  • [ 52534-29-9 ]
  • 22
  • [ 16311-69-6 ]
  • [ 622-16-2 ]
  • [ 52534-35-7 ]
  • 23
  • [ 16311-69-6 ]
  • [ 2131-61-5 ]
  • [ 20939-93-9 ]
  • 25
  • [ 16311-69-6 ]
  • [ 104-87-0 ]
  • [ 762-42-5 ]
  • dimethyl 3-(methylamino)-2-(4-methylphenyl)furan-4,5-dicarboxylate [ No CAS ]
  • 26
  • [ 16311-69-6 ]
  • [ 459-57-4 ]
  • [ 762-42-5 ]
  • dimethyl 2-(4-fluorophenyl)-3-(methylamino)furan-4,5-dicarboxylate [ No CAS ]
  • 27
  • [ 16311-69-6 ]
  • [ 100-52-7 ]
  • [ 762-42-5 ]
  • dimethyl 3-(methylamino)-2-phenylfuran-4,5-dicarboxylate [ No CAS ]
  • 28
  • [ 16311-69-6 ]
  • [ 104-88-1 ]
  • [ 762-42-5 ]
  • dimethyl 2-(4-chlorophenyl)-3-(methylamino)furan-4,5-dicarboxylate [ No CAS ]
  • 29
  • [ 16311-69-6 ]
  • [ 555-16-8 ]
  • [ 762-42-5 ]
  • dimethyl 3-(methylamino)-2-(4-nitrophenyl)furan-4,5-dicarboxylate [ No CAS ]
  • 30
  • [ 16311-69-6 ]
  • [ 120-14-9 ]
  • [ 762-42-5 ]
  • dimethyl 2-(3,4-dimethoxyphenyl)-3-(methylamino)furan-4,5-dicarboxylate [ No CAS ]
  • 31
  • [ 16311-69-6 ]
  • [ 21164-14-7 ]
YieldReaction ConditionsOperation in experiment
Representative compounds of the present invention are: ... 3-[2-(4-bromophenyl)-2-oxoethyl]-4,5-dimethylthiazolium bromide; 3-(2-methoxy-2-oxoethyl)-4-methyl-5-(2-hydroxyethyl)thiazolium bromide; 3-(2-phenyl-2-oxoethyl)-4-methyl-5-(2-hydroxyethyl)thiazolium bromide; 3-[2-(4-bromophenyl)-2-oxoethyl]-4-methyl-5-(2-hydroxyethyl)thiazolium bromide; 3,4-dimethyl-5-(2-hydroxyethyl)thiazolium iodide; 3-ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide; 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-(2-methoxy-2-oxoethyl)benzothiazolium bromide; ...
N-4-Dimethyl-5-[(2-hydroxy)ethyl]thiazolium iodide Methyl iodide (80 ml) was added to 4-methyl-5-thiazole ethanol (100 g), and the mixture was heated under reflux for 2 hours. The reaction was concentrated under reduced pressure to give a dark-brown amorphous residue. The residue was solidified by adding ether (400 ml) to the residue. The solid product was further washed twice with ether (500 ml). The powdery solid products were collected by filtration and dried under reduced pressure. Yield: 202 g. NMR (in D2 O): delta4.10 (3H, s), 3.86 (2H, m), 3.14 (2H, t), 2.48 (3H, s).
(17) 3,4-dimethyl-5-(2-hydroxyethyl)-thiazolium iodide, m.p. 85-87 C.
3,4-dimethyl-5-(2-hydroxyethyl)-thiazolium iodide, m.p. 85-87 C.
728 3,4-dimethyl-5-(2-hydroxyethyl)-thiazolium iodide, m.p. 85-87 C.
Representative, non-limiting examples of compounds of the present invention are: ... 3-[2-(4-bromophenyl)-2-oxoethyl]-4,5-dimethylthiazolium bromide; 3-(2-methoxy-2-oxoethyl)-4-methyl-5-(2-hydroxyethyl)thiazolium bromide; 3-(2-phenyl-2-oxoethyl)-4-methyl-5-(2-hydroxyethyl)thiazolium bromide; 3-[2-(4-bromophenyl)-2-oxoethyl]-4-methyl-5-(2-hydroxyethyl)thiazolium bromide; 3,4-dimethyl-5-(2-hydroxyethyl)thiazolium iodide; 3-ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide; 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride; 3-(2-methoxy-2-oxoethyl)benzothiazolium bromide; ...

  • 34
  • methyl 2-(4-fluorobenzylidene)-3-oxopentanoate [ No CAS ]
  • [ 16311-69-6 ]
  • [ 126331-19-9 ]
YieldReaction ConditionsOperation in experiment
With benzaldehyde; triethylamine; In methanol; ethanol; (b) A mixture of methyl 2-(4-fluorobenzylidene)-3-oxopentanoate (52.0 g), benzaldehyde (25.4 g), triethylamine (22 g), <strong>[16311-69-6]3,4-dimethyl-5-(2-hydroxyethyl)thiazolium iodide</strong> (6.3 g) and ethanol (100 ml) was heated at reflux under nitrogen for 16 hours. The cooled mixture was diluted with dichloromethane, and washed with dilute hydrochloric acid (2N), with dilute aqueous sodium bicarbonate solution, and with water, and dried over magnesium sulphate. The solution was concentrated in vacuo and the residue was dissolved in hot methanol. The resulting off-white solid was filtered off, to give methyl 2-(1-oxopropyl)-3-(4-fluorophenyl)-4-phenyl-4-oxobutanoate (21.5 g), m.p. 104-109 C. [Elemental analysis: C,70.1;H,5.42;F,5.58%; calculated: C,70.15;H,5.60; F,5.55%; I.R. 1749, 1738, 1716, 1708, 1679, 1508, 761, 697cm-1 [N.M.R. (in CDCl3): 0.81 and 1.08 (3H, two triplets, J=7 Hz), 1.80-2.04 and 2.46-2.80 (2H, two sets of multiplets), 3.53 and 3.68 (3H, two singlets), 4.58 and 4.62 (1H, two doublets, J=10 Hz), 5.39 and 5.42 (1H, two doublets, J=10 Hz), 6.96 (2H, t, J=8 Hz), 7.20- 7.60 (5H, m), 7.90-8.00 (2H, m)].
  • 35
  • [ 16311-69-6 ]
  • [ 6313-36-6 ]
  • [ 1333481-08-5 ]
YieldReaction ConditionsOperation in experiment
76% With sodium hydroxide; In water; at 20℃; for 1.5h;Inert atmosphere; General procedure: To a solution of quaternary ammonium salt 8 (8.90 mmol) and sodium hydroxide (17.8 mmol) in water (20 mL) was added sodium alkyl thiosulfate (26.7 mmol) under argon protection. The reaction mixture was stirred for 1.5 h at room temperature. The resultant oily substance was extracted with ethyl acetate (30 mL) and the organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification of the crude product by column chromatography with petroleum-acetone (10:1) as eluent gave a yellow syrup.
44.1% With sodium hydroxide; In water; at 20℃; for 1h;Inert atmosphere; General procedure: Under argon protection, to a 30 mL aqueous of quaternary ammonium salt 9 (14.3 g, 50.0 mmol) and sodium hydroxide (4.0 g, 100.0 mmol) was added S-substituted sodium thiosulfates 11a-11f (120.0 mmol). The reaction mixture was stirred for 1 h at room temperature. The resultant oily substance was extracted with ethyl acetate (450 mL) and the organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification of the crude product by column chromatography with dichloromethane-methanol (100:1) as eluent gave a yellow oil.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 16311-69-6 ]

Alcohols

Chemical Structure| 137-00-8

A191724 [137-00-8]

4-Methyl-5-thiazoleethanol

Similarity: 0.86

Chemical Structure| 67-03-8

A241911 [67-03-8]

3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-5-(2-hydroxyethyl)-4-methylthiazol-3-ium chloride hydrochloride

Similarity: 0.67

Chemical Structure| 496062-16-9

A282731 [496062-16-9]

2-Bromo-4-(2-hydroxyethyl)-5-methylthiazole

Similarity: 0.66

Chemical Structure| 394223-37-1

A147110 [394223-37-1]

Benzo[d]thiazol-5-ylmethanol

Similarity: 0.64

Chemical Structure| 50382-32-6

A123688 [50382-32-6]

(2,4-Dimethylthiazol-5-yl)methanol

Similarity: 0.60

Related Parent Nucleus of
[ 16311-69-6 ]

Thiazoles

Chemical Structure| 137-00-8

A191724 [137-00-8]

4-Methyl-5-thiazoleethanol

Similarity: 0.86

Chemical Structure| 90731-56-9

A108207 [90731-56-9]

2-(4-Methylthiazol-5-yl)ethyl formate

Similarity: 0.79

Chemical Structure| 656-53-1

A131358 [656-53-1]

2-(4-Methylthiazol-5-yl)ethyl acetate

Similarity: 0.75

Chemical Structure| 17928-09-5

A152972 [17928-09-5]

2-(4-Methylthiazol-5-yl)ethanamine hydrochloride

Similarity: 0.75

Chemical Structure| 3581-91-7

A200332 [3581-91-7]

4,5-Dimethylthiazole

Similarity: 0.68